Overview * France-U.S. spine surgery firm's H1 sales rose 3% to €5.1 mln, topping €5 mln for first time * U.S. sales up 10% in dollars, but euro growth limited by currency and surgeon absence *
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)